Invesco Ltd. boosted its holdings in Chemed Co. (NYSE:CHE - Free Report) by 4.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 182,144 shares of the company's stock after acquiring an additional 6,957 shares during the quarter. Invesco Ltd. owned 1.21% of Chemed worth $96,500,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. CIBC Asset Management Inc raised its stake in shares of Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after acquiring an additional 22 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its stake in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares during the last quarter. CIBC Private Wealth Group LLC grew its position in Chemed by 13.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after purchasing an additional 22 shares during the last quarter. Independent Advisor Alliance raised its holdings in Chemed by 1.1% in the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after acquiring an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Chemed by 7.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after purchasing an additional 33 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.
Insider Buying and Selling at Chemed
In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This trade represents a 0.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.32% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
CHE has been the subject of several analyst reports. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada increased their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th.
View Our Latest Stock Report on Chemed
Chemed Stock Performance
CHE stock traded down $12.42 during trading on Tuesday, reaching $588.27. 106,219 shares of the company traded hands, compared to its average volume of 97,457. The company has a market capitalization of $8.60 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The business has a 50 day simple moving average of $584.60 and a 200 day simple moving average of $567.87. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is 10.05%.
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.